UOC
GRNAW

UBS O'Connor’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

UBS O'Connor’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-307,115
Closed -$365K – 465
2021
Q4 		$365K Buy
307,115
+7,126
+2% +$8.13K ﹤0.01% 699
2021
Q3 		$306K Hold
299,989
– – ﹤0.01% 680
2021
Q2 		$334K Buy
299,989
+196
+0.1% +$173 ﹤0.01% 659
2021
Q1 		$259K Buy
+299,793
New +$312K ﹤0.01% 662

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

UBS O'Connor's GRNAW Position: Q1 2022 in Review

UBS O'Connor sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q1 2022, closing a stake of 307,115 shares — an estimated $365K sold.

UBS O'Connor first reported a position in GRNAW in Q1 2021 and held it in 4 quarters. The position peaked at $365K in Q4 2021. 27 funds tracked by Wall St. Rank hold GRNAW as of Q1 2022.

  • UBS O'Connor reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 307,115 GreenLight Biosciences Holdings, PBC Warrant shares in Q1 2022, an estimated $365K.
  • UBS O'Connor first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's GreenLight Biosciences Holdings, PBC Warrant position peaked at $365K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.